DJIA 18,134.20 37.30 0.21%
NASDAQ 4,983.74 16.60 0.33%
S&P 500 2,100.90 2.37 0.11%
market minute promo

429.63 16.59 (4.02%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $429.58 4.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $414.93
Previous Close $413.04
Daily Range $414.21 - $430.29
52-Week Range $269.50 - $437.64
Market Cap $44.1B
P/E Ratio 134.54
Dividend (Yield) $0.00 (0.0%)
Volume 862,267
Average Daily Volume 774,047
Current FY EPS $7.79

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary Rss Feed

Billions on the Line in the Next Drug Pricing War

Could approval of two new cholesterol drugs lead to another high stakes pricing war?

Novartis Sees Past Lucentis's Decline

The 5 Most Loved Biotech Stocks of Portfolio Managers

6 stocks that left the bull market in the dust

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst B

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog

Can These Three BioTech Companies Make It Big?

Comparing America's Next 3 Biotechnology Companies

Regeneron's Eylea Tops Diabetic Macular Edema Study - Analyst Blog

Thursday's ETF Movers: PBE, ICF

Nasdaq 100 Movers: VIP, PCLN

See More REGN News...

REGN's Top Competitors

REGN $429.63 (4.02%)
Current stock: REGN
AMGN $159.50 (0.19%)
Current stock: AMGN
GILD $103.57 (0.49%)
Current stock: GILD
BIIB $423.82 (2.34%)
Current stock: BIIB